Cargando…
Abstract 11: A Novel Tissue Engineered Three-Dimensional Biomimetic Platform for In Vitro Study of BIA-ALCL
Autores principales: | Wright, Matthew A., Lara, Daniel O., Samadi, Arash, Toyoda, Yoshiko, Celie, Karel-Bart, Zhao, Runlei, Inghirami, Giorgio G., Brown, Kristy A., Spector, Jason A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6504470/ http://dx.doi.org/10.1097/01.GOX.0000558285.07813.05 |
Ejemplares similares
-
Abstract QS36: A Vascularized, Three-dimensional Biomimetic Platform for Patient-Specific, ex-vivo studies of Breast Cancer Invasion and Metastasis
por: Lara, Daniel, et al.
Publicado: (2019) -
Abstract 33: Understanding the Role of Adipocytes and the Tumor Microenvironment on Doxorubicin Therapy of Breast Cancer in a Tissue Engineered, Patient Specific, High-throughput Biomimetic Platform
por: Lara, Daniel, et al.
Publicado: (2019) -
Abstract 125: Silicone Implant Shells Increase The Rate Of Proliferation Of Patient-derived BIA-ALCL Cells But Not Primary T Cells In An Engineered Biomimetic Patient-derived Breast Tissue
por: Premaratne, Ishani D., et al.
Publicado: (2020) -
Abstract 56: A Patient Specific Tissue Engineered Biomimetic Platform For High Throughput Analysis Of Breast Cancer Therapeutic Options
por: Toyoda, Yoshiko, et al.
Publicado: (2018) -
Abstract 31: A Systematic Review of Breast-Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Past and Current Knowledge
por: ElHawary, Hassan, et al.
Publicado: (2019)